Ciara C. O’Sullivan of Mayo Clinic, leads the Alliance A011801 trial – Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology shared on LinkedIn:

“For Trial Tuesday, Ciara C. O’Sullivan, MB, BCh, of Mayo Clinic, leads the Alliance A011801 (CompassHER2 RD) trial to see how targeted therapy linked to a chemotherapy drug works to prevent breast cancer from returning in patients with high-risk HER2+ breast cancer. To learn more about the CompassHER2 RD trial.”

Further Reading.
Source: Alliance for Clinical Trials in Oncology/LinkedIn